Striatal monoamines and reserpine and chlorpromazine rigidity.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism* / Q000502:physiology; D004298:Dopamine / Q000502:physiology; D006801:Humans; D051379:Mice; D009046:Motor Neurons / Q000187:drug effects; D009127:Muscle Rigidity / Q000139:chemically induced*; D010275:Parasympathetic Nervous System / Q000502:physiology; D010276:Parasympatholytics / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013378:Substantia Nigra / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology
D001679:Biogenic Amines; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D012110:Reserpine; D002746:Chlorpromazine; D004298:Dopamine